The Latest in Psoriatic Arthritis

Abatacept makes inroads in psoriatic arthritis

November 15, 2016

Psoriatic Arthritis

VIDEO: Consider comorbidities when preparing patients for systemic psoriasis therapy

November 11, 2016

Psoriatic Arthritis

Optimize anti–TNF-alpha therapy for psoriasis

November 11, 2016

Psoriatic Arthritis

VIDEO: IL-23 inhibitors on the upswing

November 11, 2016

Psoriatic Arthritis

Study offers reassuring data on certolizumab use in pregnancy

November 10, 2016

What good are biosimilars if patients won’t use them?

November 5, 2016

FDA’s Woodcock: Give biosimilars a chance

November 5, 2016

Biosimilars face barriers to broader acceptance

November 4, 2016

PsA bone loss measurement: A surrogate for radiographic progression?

November 1, 2016

Psoriatic Arthritis

Tildrakizumab for psoriasis scores high marks in phase III

October 19, 2016

Psoriatic Arthritis

Secukinumab for psoriasis at 4 years: undiminished efficacy and safety

October 18, 2016

Psoriatic Arthritis

Guselkumab achieves highest-ever response rates in psoriasis

October 12, 2016

Psoriatic Arthritis

Birth outcomes unaffected by paternal immunosuppressive therapy

October 12, 2016

Severe joint pain in adults with arthritis continues to rise

October 11, 2016

Most children with JIA get different diagnosis as adults

October 4, 2016